# Clinical differences between Raoultella spp. and Klebsiella oxytoca

**Authors:** Sofia K. Mettler, Nipith Charoenngam, Robert C. Colgrove

PMC · DOI: 10.3389/fcimb.2024.1260212 · Frontiers in Cellular and Infection Microbiology · 2024-06-03

## TL;DR

This study compares clinical features of Raoultella and Klebsiella oxytoca infections, finding differences in ICU admissions and infection sites.

## Contribution

The study provides new clinical insights into the differences in disease severity and infection sites between Raoultella and Klebsiella oxytoca.

## Key findings

- Raoultella infections were more likely to require ICU admission compared to Klebsiella oxytoca.
- Raoultella caused more bloodstream infections, while Klebsiella oxytoca was more common in the respiratory tract.
- Both species showed similar antibiotic susceptibility profiles except for Trimethoprim/sulfamethoxazole.

## Abstract

Raoultella spp. is a genus of bacteria that is known to be closely related to Klebsiella. It has been debated whether Raoultella should be reclassified as a subgroup of Klebsiella. The aim of this study is to compare clinical aspects of Raoultella and Klebsiella oxytoca, a species of Klebsiella that is known to be bacteriologically similar to Raoultella spp.

Using data collected at a tertiary care hospital in the United States, we identified 43 patients with Raoultella infection and 1173 patients with Klebsiella oxytoca infection. We compared patient demographics (age and sex), hospitalization status, isolation sites and antibiotic resistance profiles between the two species.

There was no significant difference in patient demographics between the two bacteria species. The proportions of intensive care unit (ICU) admission were higher among patients with Raoultella infection (p=0.008). The most common site of isolation was urine for both species (39.5% of all patients with Raoultella spp. vs. 59.3% for K. oxytoca). The second most common site of isolation was blood stream for Raoultella spp. (23.3%) and respiratory tract for K. oxytoca (10.8%). Except for the high proportion of resistant isolates of Raoultella spp. for Trimethoprim/sulfamethoxazole, the antibiotic susceptibility profiles were similar between the two bacteria species. Both were susceptible to ciprofloxacin and meropenem.

While there are no significant differences in the patient demographics and antibiotic susceptibility profiles between Raoultella spp. and K. oxytoca, Raoultella may cause more serious infection requiring ICU admissions. Also, Raoultella may cause blood stream infection more frequently than K. oxytoca.

## Linked entities

- **Chemicals:** Trimethoprim/sulfamethoxazole (PubChem CID 358641), ciprofloxacin (PubChem CID 2764), meropenem (PubChem CID 441130)
- **Species:** Klebsiella oxytoca (taxon 571)

## Full-text entities

- **Diseases:** Klebsiella oxytoca infection (MESH:D007710), blood stream infection (MESH:D000086982), Raoultella infection (MESH:D007239)
- **Chemicals:** meropenem (MESH:D000077731), ciprofloxacin (MESH:D002939), Trimethoprim/sulfamethoxazole (MESH:D015662)
- **Species:** Homo sapiens (human, species) [taxon 9606], Klebsiella oxytoca (species) [taxon 571], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Raoultella [taxon 160674]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11180880/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11180880/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11180880/full.md

---
Source: https://tomesphere.com/paper/PMC11180880